The Elderly Patient with Pancreatic Cancer: Trends and Medical Oncology

2021 ◽  
pp. 595-611
Author(s):  
Lydia van der Geest ◽  
Johanneke Portielje ◽  
Hanneke Wilmink
Keyword(s):  
Pancreatic Cancer ◽  
Elderly Patient ◽  
Medical Oncology ◽  
The Elderly ◽  
Cancer Trends

Surgery/Interventions in the Elderly Patient with Pancreatic Cancer

2021 ◽  
pp. 613-629
Author(s):  
Tyler R. Chesney ◽  
Ines Menjak ◽  
Barbara Haas ◽  
Sten Myrehaug ◽  
Julie Hallet
Keyword(s):  
Pancreatic Cancer ◽  
Elderly Patient ◽  
The Elderly

Creating a Safer Patient Room Environment: The Contribution of Patient Bed Height

2021 ◽  
Vol 10 (1) ◽  
pp. 180-184
Author(s):  
Dorothy Taylor ◽  
Janice Morse ◽  
Andrew Merryweather
Keyword(s):  
Elderly Patient ◽  
Fall Risk ◽  
The Elderly ◽  
Lower Leg ◽  
Patient Specific ◽  
Leg Length ◽  
Patient Room ◽  
Patient Falls ◽  
Sit To Stand ◽  
Bed Height

Elderly patient falls are expensive and may cause serious harm. Studies have identified the sit-to-stand-and-walk (STSW) task as the task where the greatest number of elderly patient falls occur. There is a great need to identify the particular movement and environmental conditions that lead to these elderly patient falls. This study begins to address this gap by evaluating the elderly patient during self-selected hospital bed egress. Using an observed fall risk episode (FRE) as a fall proxy, statistically significant parameters were identified which include bed height, pausing prior to initiating gait, level of fall risk, and Stand phase. Low bed height was identified as the least safe bed height. Patient-specific bed height (PSBH) using the patient’s lower leg length (LLL) is recommended. In addition, suggested guidelines are presented for clinical application in setting PSBH without measuring the patient’s LLL.

scholarly journals ESMO 2020 update: Pancreatic cancer

2021 ◽  
Author(s):  
Elisabeth Sophie Bergen
Keyword(s):  
Pancreatic Cancer ◽  
Randomized Clinical Trials ◽  
Medical Oncology ◽  
Chemotherapy Regimen ◽  
Ductal Adenocarcinoma ◽  
First Line ◽  
Standard Chemotherapy ◽  
Trial Quality ◽  
Standard Chemotherapy Regimen

SummaryAt the ESMO (European Society for Medical Oncology) 2020 several interesting albeit not practice-changing studies in the field of pancreatic cancer were presented. The Canadian phase II randomized PA.7 trial investigated the additional benefit of dual checkpoint inhibition with durvalumab and tremelimumab to a standard chemotherapy regimen as first-line treatment in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). Unfortunately, no significant improvement of responses or outcome could be achieved rendering this study a negative trial. Within the German platform-based QoliXane trial, quality of life was shown to be an essential prognosticator of survival with fatigue and nausea being independently associated with outcome of patients. Moreover, promising results could be observed with new targeted therapy approaches, which may lead to its investigation in larger randomized clinical trials.

Odontoid Fractures, with Special Reference to the Elderly Patient

1985 ◽  
Vol &NA; (193) ◽  
pp. 178???183 ◽  
Author(s):  
J. W. PEPIN ◽  
R. B. BOURNE ◽  
R. J. HAWKINS
Keyword(s):  
Elderly Patient ◽  
Special Reference ◽  
The Elderly ◽  
Odontoid Fractures

The Elderly Patient

1968 ◽  
Vol 23 (4) ◽  
pp. 563-563
Author(s):  
H. A. Illing
Keyword(s):  
Elderly Patient ◽  
The Elderly

Propofol Versus Midazolam/Fentanyl Sedation for Colonoscopy in the Elderly Patient Population

2017 ◽  
Vol 32 (3) ◽  
pp. 210-214 ◽  
Author(s):  
Pamela Lovett ◽  
Victoria Gómez ◽  
David O. Hodge ◽  
Beth Ladlie
Keyword(s):  
Elderly Patient ◽  
Patient Population ◽  
The Elderly
Sign in / Sign up

Export Citation Format

Share Document